GLP-1 use varies widely across US for youths with type 2 diabetes

NEW ORLEANS — Fewer than half of children and adolescents with type 2 diabetes are prescribed GLP-1 receptor agonists at most pediatric diabetes centers in the T1D Exchange Quality Improvement Collaborative, according to survey data. At the American Diabetes Association Scientific Sessions, researchers from the T1D Exchange Quality Improvement Collaborative presented results from a survey of its